(founded in 1995, 20 employees in medical technology) is a company of the FIT Additive Manufacturing Group and has specialized in additive engineering, serial production, mass customization and single part manufacturing in industries such as automotive and motorsports, aviation and aerospace, mechanical engineering and medical technology.
Currently, one in four deaths is caused by cancer – mainly as a result of metastatic disease spread. Thus, the Project Group concentrates on the development of diagnostic tests to detect disseminated cancer cells early in the disease and to predict the response to therapy of metastatic progenitor cells.
FUTUR (Forschungs- und Technologietransfer Universität Regensburg) is Regensburg University’s multidisciplinary service facility for knowledge and technology transfer. It is a link between private business and university research.